ESEduardo Becquer Carrasco Solis

Eduardo Becquer Carrasco Solis

*This is an algorithmically generated author record based on publicly available information.

Eduardo Becquer Carrasco Solis has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Establishment of local diagnostic reference levels in mammography: multicenter retrospective study in Trujillo, Peru

    by Cecilia Querebalu Garcia, Paul Elias Panizo Olivos, Eduardo Garnique Millones, Christian Heyrner Barragan Mondragon, José Fernando Márquez Pachas, Eduardo Becquer Carrasco Solis

    Radiation exposure in mammography can vary considerably across centers, potentially affecting both diagnostic quality and patient safety. In Trujillo, Peru, no locally adjusted absorbed dose values were previously available. Therefore, the objective of this study was to establish local diagnostic reference levels (LDRLs) for digital mammography within the EsSalud hospital network (Social Health Insurance) in Trujillo. A retrospective, multicenter study was conducted in three hospitals, analyzing 133 digital mammograms acquired with Hologic Selenia Dimensions systems. Technical parameters such as kilovoltage, tube load, compression force, compressed breast thickness, and average glandular dose (AGD) were collected and processed using automated systems. The LDRLs, defined as the 75th percentile of the AGD distribution, were determined for the craniocaudal (CC) and mediolateral oblique (MLO) projections. Multiple linear regression analysis was performed to identify independent predictors of AGD. The proposed LDRLs were 1.78 mGy for CC and 2.12 mGy for MLO, values well below the reference level of 3 mGy recommended by the Basic Safety Standards of the International Atomic Energy Agency (IAEA), and 30 − 39% lower than the regional LDRLs previously reported for direct digital radiography (DDR) systems in Latin America. Tube load (β = 0.886, p < 0.001 for CC; β = 0.572, p < 0.001 for MLO) and compressed breast thickness (β = 0.193, p < 0.001 for CC; β = 0.297, p = 0.001 for MLO) were identified as the most significant technical predictors of AGD. The established LDRLs demonstrate optimized dosimetric practices within the EsSalud network in Trujillo, ensuring that patient doses are appropriate, consistent, and aligned with international standards. Their implementation will facilitate ongoing dose monitoring, protocol standardization, and the strengthening of radiation protection in breast cancer screening programs.

  • Open Access

    Synthesis, Antitubercular Activity, and Computational Characterization of Novel Phenylpyrazole‐Isoniazid Derivatives

    by Fernando Carrasco, Wilfredo Hernández, Juan Z. Dávalos, Jackeline Mosquera, Oscar Chupayo, Nelly Sivipaucar, Jaime Tamayo, Eduardo Carrasco-S, Jorge Coronel, Osvaldo Yañez, et al.

    Six new phenyl‐1 H ‐pyrazole‐carbaldehyde isonicotinylhydrazone derivatives 1-10 were synthesized and characterized by spectroscopic (FT‐IR, 1H NMR, and 13C NMR) techniques and electrospray ionization–mass spectrometry (ESI–MS). Homonuclear data from 2D‐NMR ( 1 H‐ 1 H NOESY) revealed that 3 and 5 adopt the transE isomeric form. The in vitro antitubercular activity of all the synthesized compounds was determined against Mycobacterium tuberculosis (sensitive H37RV and resistant TB DM97). With respect to the isoniazid (INH) standard drug (MIC = 0.91 μM), all the prepared compounds showed greater antitubercular activity with MIC values in the range of 0.38–0.82 μM against Mtb H37Rv‐sensitive strain. However, the preliminary results indicated that Compounds 1 – 10 tested against the TB DM97‐resistant strain showed low bioactivity. The optimized geometry of Compounds 1 – 10 has been determined by density functional theory (DFT) calculations. For Compounds 1 – 6 , the most stable isomers (in DMSO) exhibited an E geometrical configuration, while Compounds 7–10 exhibited a Z configuration. The global reactivity values indicate that Compounds 1 – 10 are slightly more reactive and less stable than the standard (INH). Additionally, they exhibit a strong binding capacity to biomolecules, comparable to INH. The MEP map reveals that the negative and positive potential sites are predominantly located on the C=O and HN–NH groups, respectively, similar to those observed for INH. Drug‐likeness and ADME properties were evaluated. All compounds showed adequate ADME properties and are drug‐like. Molecular docking studies (Compounds 1 – 10 ) into the active site of mycobacterial InhA showed an acceptable dissociation constant with improved binding energy (from −6.7 to −8.1 kcal mol −1 ) compared to isoniazid (−5.6 kcal mol −1 ). Molecular dynamics simulations revealed that the molecules cmp3 (3) and cmp5 (5) form stable ternary complexes with InhA through persistent hydrogen bonding and hydrophobic interactions. These compounds showed reduced active‐site fluctuations and superior binding free energies compared to INH. The findings represent a significant advancement in the discovery of potential antitubercular agents.